Alembic Pharmaceuticals Limited announces USFDA final approval for Tretinoin Cream USP, 0.05%
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.05%.